Role of Bone Marrow-Derived Mesenchymal Stem Cells in Healing of Femoral Bone Defect in Rat Model: Behavioral Psychomotor Performance, Oxidative-inflammatory Markers, Osteoblast Markers and Mesenchymal Stem Cell Growth Factors.
Lotfy, F., Atta, R., El-Kherbetawy, M., Ibrahim, D. (2023). Role of Bone Marrow-Derived Mesenchymal Stem Cells in Healing of Femoral Bone Defect in Rat Model: Behavioral Psychomotor Performance, Oxidative-inflammatory Markers, Osteoblast Markers and Mesenchymal Stem Cell Growth Factors.. EKB Journal Management System, 26(8), 1-15. doi: 10.21608/scumj.2023.322603
Fatma A. Lotfy; Rasha Atta; Mohamed K. El-Kherbetawy; Dalia Ibrahim. "Role of Bone Marrow-Derived Mesenchymal Stem Cells in Healing of Femoral Bone Defect in Rat Model: Behavioral Psychomotor Performance, Oxidative-inflammatory Markers, Osteoblast Markers and Mesenchymal Stem Cell Growth Factors.". EKB Journal Management System, 26, 8, 2023, 1-15. doi: 10.21608/scumj.2023.322603
Lotfy, F., Atta, R., El-Kherbetawy, M., Ibrahim, D. (2023). 'Role of Bone Marrow-Derived Mesenchymal Stem Cells in Healing of Femoral Bone Defect in Rat Model: Behavioral Psychomotor Performance, Oxidative-inflammatory Markers, Osteoblast Markers and Mesenchymal Stem Cell Growth Factors.', EKB Journal Management System, 26(8), pp. 1-15. doi: 10.21608/scumj.2023.322603
Lotfy, F., Atta, R., El-Kherbetawy, M., Ibrahim, D. Role of Bone Marrow-Derived Mesenchymal Stem Cells in Healing of Femoral Bone Defect in Rat Model: Behavioral Psychomotor Performance, Oxidative-inflammatory Markers, Osteoblast Markers and Mesenchymal Stem Cell Growth Factors.. EKB Journal Management System, 2023; 26(8): 1-15. doi: 10.21608/scumj.2023.322603

Role of Bone Marrow-Derived Mesenchymal Stem Cells in Healing of Femoral Bone Defect in Rat Model: Behavioral Psychomotor Performance, Oxidative-inflammatory Markers, Osteoblast Markers and Mesenchymal Stem Cell Growth Factors.

Suez Canal University Medical Journal
Article 1, Volume 26, Issue 8, August 2023, Page 1-15  XML PDF (680.45 K)
Document Type: Original Article
DOI: 10.21608/scumj.2023.322603
View on SCiNiTO View on SCiNiTO
Authors
Fatma A. Lotfy1; Rasha Atta email orcid 1; Mohamed K. El-Kherbetawy2; Dalia Ibrahim1
1Department of Physiology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
2Department of Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Abstract
Background: Various techniques have been used to restore large bone abnormalities, but they have limitations. Mesenchymal stem cells (MSCs) have the potential to differentiate into bone tissue and are a promising candidate for cell therapy. Aim: This study aimed to investigate the effectiveness of using bone marrow-derived mesenchymal stem cells (MSCs) to treat femoral bone defects in rats. Material and Methods: The study was carried out in the Faculty of Medicine, Suez Canal University. The study involved dividing 27 male rats into control, defect, and stem cell-treated groups. The rats' locomotor activity, oxidative stress, inflammatory markers [tumor necrosing factor (TNF-α) and interleukin (IL-6)], angiogenic markers, osteoblast markers [Osteopontin and transforming growth factor (TGF-β)], and bone healing were assessed through various tests and measurements (histologically and radiologically). Results: The stem cell-treated group exhibited significantly improved locomotor activity, levels of inflammatory markers, total antioxidant capacity, and osteoblast markers compared to the defect group. Histological and radiological assessments indicated improvements in the stem cell-treated group. Conclusion: bone marrow-derived MSCs can enhance experimental bone healing by modulating oxidative stress, and inflammatory and angiogenic markers leading to improved locomotor parameters.
 
Keywords
bone healing; bone marrow-derived mesenchymal stem cells; total antioxidant; Osteopontin; transforming growth factor-beta
Statistics
Article View: 103
PDF Download: 29